BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Medical Diagnostic

Bio-Techne Opens Düsseldorf Flagship Centre to Accelerate Life Sciences Innovation Across Europe

New flagship facility provides hands-on access to Bio-Techne technologies, workflows and scientific expertise Regional hub will support researchers and ...

September 24, 2026 | News

Mayo Clinic Laboratories Invests in Pathology Asia to Expand Precision Diagnostics Across APAC

Mayo Clinic Laboratories and Pathology Asia Holdings (PAH) have announced a strategic investment and collaboration aimed at expanding access to a...

September 23, 2026 | News

IMPACT Therapeutics, Pharmanovia’s Senaparib Secures EU Panel Backing for Ovarian Cancer

MPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based...

September 21, 2026 | News

Massive Bio Targets South Korea Expansion for AI-Powered Oncology Trial Matching

US healthtech company Massive Bio has appointed international business development consultancy Intralink to support its expansion into South Korea and buil...

September 21, 2026 | News

Ferronova’s Nanoparticle Platform Shows Promise for More Precise Gastric and Oesophageal Cancer Surgery

Australian medical technology company Ferronova has announced preliminary findings from the MAGMAP multi-centre trial involving 62 gastric and oesopha...

September 17, 2026 | News

Takeda’s Zasocitinib Receives US FDA Priority Review for Plaque Psoriasis

-Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) under Priority Review for za...

September 16, 2026 | News

Bausch + Lomb Secures European CE Mark for Next-Generation SeeLyra Femtosecond Laser

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced European C...

September 14, 2026 | News

MEDIPAL, JCR Dose First Patient in Global Phase I/II Trial of JR-446 for Sanfilippo Syndrome

-MEDIPAL HOLDINGS CORPORATION (TSE 7459, MEDIPAL) and JCR Pharmaceuticals Co., Ltd. (TSE 4552, JCR) announced that the first participa...

September 14, 2026 | News

Exegenesis Bio, Modalis Partner to Advance CRISPR-Based DMD Therapy MDL-201

Exegenesis Bio and Modalis Therapeutics Corporation (TOKYO: 4883; "Modalis") announced that they have signed a research collaboration and license agr...

September 14, 2026 | News

Kelun-Biotech’s Twice-Yearly Asthma Candidate SKB378 Advances into Phase III

The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the interim analysis was conducted on the first 98 patients. ...

September 10, 2026 | News

Dimerix Secures A$34M Non-Dilutive Funding to Advance Kidney Disease Pipeline Subheadline:

Dimerix successfully enters into non-dilutive facility agreements to access A$34 million[1] with a syndicate of Australian and U.S. independent lend...

September 07, 2026 | News

Convergen Raises $15M Seed+ to Accelerate Targeted Protein Degradation Therapies

Convergen, a biotechnology company pioneering targeted protein degradation (TPD) therapies for diseases driven by pathological protein aggregates, an...

September 02, 2026 | News

Astellas Reaches US Government Agreement to Lower Medicaid Drug Prices, Strengthen Medicine Supply Chain

Agreement supports commitment to patient access, affordability and innovation – Astellas Pharma Inc. announced that it has reached an agreemen...

September 02, 2026 | News

SIBIONICS Showcases AI-Powered GS3 Glucose Monitoring, Advances Integrated Diabetes Care at Melbourne Congress

SIBIONICS showcased its sensor innovation and AI-powered glucose monitoring at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress, held in Melbour...

September 01, 2026 | News

Stay Connected